Evidence map›Paper›PMID 25710625›Full record

ArticlePloS one2015

Positive influence of being overweight/obese on long term survival in patients hospitalised due to acute heart failure.

Simona Littnerova, Jiri Parenica, Jindrich Spinar, Jirí Vitovec, Ales Linhart, Petr Widimsky, Jiri Jarkovsky, Roman Miklik, Lenka Spinarova, Kamil Zeman and 22 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Article
  3. Obesity Paradox: Fact or Fiction?Current obesity reports · 2023
    Review
  4. Article
  5. Article
  6. Obesity paradox and heart failure.Eating and weight disorders : EWD · 2021
    Review
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 11 institutions in 1 country.

Simona LittnerovaInstitute of Biostatistics and Analysis, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Jiri ParenicaDepartment of Cardiology, University Hospital Brno, Brno, Czech Republic; Medical Faculty, Masaryk University, Brno, Czech Republic; Department of Cardiovascular Disease, International Clinical Research Center, University Hospital St Anne's, Brno, Czech Republic.
Jindrich SpinarDepartment of Cardiology, University Hospital Brno, Brno, Czech Republic; Medical Faculty, Masaryk University, Brno, Czech Republic; Department of Cardiovascular Disease, International Clinical Research Center, University Hospital St Anne's, Brno, Czech Republic.
Jirí VitovecMedical Faculty, Masaryk University, Brno, Czech Republic; First Department of Cardiovascular Internal Medicine, University Hospital St Anne's, Brno, Czech Republic.
Ales Linhart2nd Department of Cardiovascular Internal Medicine, First Medical Faculty, Charles University, Prague and General Teaching Hospital of Prague, Prague, Czech Republic.
Petr WidimskyKralovske Vinohrady University Hospital and the 3rd Faculty of Medicine, Charles University, Prague, Czech Republic.
Jiri JarkovskyInstitute of Biostatistics and Analysis, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Roman MiklikDepartment of Cardiology, University Hospital Brno, Brno, Czech Republic; Department of Cardiovascular Disease, International Clinical Research Center, University Hospital St Anne's, Brno, Czech Republic.
Lenka SpinarovaMedical Faculty, Masaryk University, Brno, Czech Republic; First Department of Cardiovascular Internal Medicine, University Hospital St Anne's, Brno, Czech Republic.
Kamil ZemanDepartment of Internal Medicine, Hospital Frydek-Mistek, Frydek-Mistek, Czech Republic.
Jan Belohlavek2nd Department of Cardiovascular Internal Medicine, First Medical Faculty, Charles University, Prague and General Teaching Hospital of Prague, Prague, Czech Republic.
Filip MalekDepartment of Cardiology, Na Homolce Hospital, Prague, Czech Republic.
Marian FelsociDepartment of Cardiology, University Hospital Brno, Brno, Czech Republic; Department of Cardiovascular Disease, International Clinical Research Center, University Hospital St Anne's, Brno, Czech Republic.
Jiri KettnerDepartment of Cardiology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic.
Petr OstadalDepartment of Cardiology, Na Homolce Hospital, Prague, Czech Republic.
Cestmir CihalikDepartment of Internal Medicine, University Hospital Olomouc, Olomouc, Czech Republic.
Jiri SpacMedical Faculty, Masaryk University, Brno, Czech Republic; 2nd Department of Internal Medicine, University Hospital St Anne's, Brno, Czech Republic.
Hikmet Al-HitiDepartment of Cardiology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic.
Marian FedorcoDepartment of Internal Medicine, University Hospital Olomouc, Olomouc, Czech Republic.
Richard FojtKralovske Vinohrady University Hospital and the 3rd Faculty of Medicine, Charles University, Prague, Czech Republic.
Andreas KrugerDepartment of Cardiology, Na Homolce Hospital, Prague, Czech Republic.
Josef MalekDepartment of Internal Medicine, Hospital Havlickuv Brod, Havlickuv Brod, Czech Republic.
Tereza MikusováFirst Department of Cardiovascular Internal Medicine, University Hospital St Anne's, Brno, Czech Republic.
Zdenek MonhartDepartment of Internal Medicine, Hospital Znojmo, Znojmo, Czech Republic.
Stanislava BohacovaDepartment of Cardiology, T.Bata Hospital Zlin, Zlin, Czech Republic.
Lidka PohludkovaDepartment of Internal Medicine, Hospital Frydek-Mistek, Frydek-Mistek, Czech Republic.
Filip RohacKralovske Vinohrady University Hospital and the 3rd Faculty of Medicine, Charles University, Prague, Czech Republic.
Jan VaclavikDepartment of Internal Medicine, University Hospital Olomouc, Olomouc, Czech Republic.
Dagmar VondrakovaDepartment of Cardiology, Na Homolce Hospital, Prague, Czech Republic.
Klaudia VyskocilovaFirst Department of Cardiovascular Internal Medicine, University Hospital St Anne's, Brno, Czech Republic.
Miroslav BambuchDepartment of Cardiology, T.Bata Hospital Zlin, Zlin, Czech Republic.
Ladislav DusekInstitute of Biostatistics and Analysis, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Masaryk University · CZNa Homolce Hospital · CZUniversity Hospital Brno · CZCharles University · CZSt. Anne's University Hospital Brno · CZUniversity Hospital Olomouc · CZGeneral University Hospital in Prague · CZInstitute of Clinical and Experimental Medicine · CZKrajská nemocnice T. Bati · CZHavlíčkův Brod Hospital · CZNemocnice Znojmo · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundObesity is clearly associated with increased morbidity and mortality rates. However, in patients with acute heart failure (AHF), an increased BMI could represent a protective marker. Studies evaluating the "obesity paradox" on a large cohort with long-term follow-up are lacking.

methodsUsing the AHEAD database (a Czech multi-centre database of patients hospitalised due to AHF), 5057 patients were evaluated; patients with a BMI <18.5 kg/m2 were excluded. All-cause mortality was compared between groups with a BMI of 18.5-25 kg/m2 and with BMI >25 kg/m2. Data were adjusted by a propensity score for 11 parameters.

resultsIn the balanced groups, the difference in 30-day mortality was not significant. The long-term mortality of patients with normal weight was higher than for those who were overweight/obese (HR, 1.36; 95% CI, 1.26-1.48; p<0.001)). In the balanced dataset, the pattern was similar (1.22; 1.09-1.39; p<0.001). A similar result was found in the balanced dataset of a subgroup of patients with de novo AHF (1.30; 1.11-1.52; p = 0.001), but only a trend in a balanced dataset of patients with acute decompensated heart failure.

conclusionThese data suggest significantly lower long-term mortality in overweight/obese patients with AHF. The results suggest that at present there is no evidence for weight reduction in overweight/obese patients with heart failure, and emphasize the importance of prevention of cardiac cachexia.

Indexed as

Acute DiseaseAgedBody Mass IndexCohort StudiesDatabases, FactualFemaleFollow-Up StudiesHeart FailureHospitalizationHumansMaleMiddle AgedObesityOverweightProportional Hazards ModelsSurvival Analysis

Identifiers

PMID25710625
PMCPMC4339191
OpenAlexW2067520645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.